Zusammenfassung
The excellent progress which has been made during the last 3 decades in the treatment of acute lymphoblastic leukemia (ALL) in children is well known, and it appears that about half of children with ALL are now probably being cured with the best therapeutic programs [1–4]. Using the same or similar treatment protocols, the results of treatment of adults with ALL have generally been less favorable, especially with regard to the proportion of long survivors [5–15], but recently several groups, including our own, have reported improved results with intensive treatment regimens which are more nearly comparable to those in children [16–21].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
George SL, Aur RJA, Mauer A, Simone JV (1979) A reappraisal of the results of stopping therapy in childhood leukemia. NEJM 300:269–273
Haghbin M, Murphy ML, Tan CC, Clarkson BD, Thaler HT, Passe S, Burchenal JH (1980) A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer 46:241–252
Riehm H, Gadner H, Henze G, Langermann HJ, Odenwald E (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970–1976. Am J Pediatr Hematol Oncol 2:299
Nesbit ME, Sather H, Robison LL, Donaldson M, Littmann P, Ortega JA, Hammond GD (1982) Sanctuary Therapy: A randomized trial of 724 children with previously untreated acute lymphoblastic leukemia. A report from Childrens Cancer Study Group. Cancer Res 42:674–680
Gee TS, Haghbin M, Dowling MD, Cunningham I, Middleman MP, Clarkson BD (1976) Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. Cancer 37:1256–1264
Sackmann-Muriel F, Svarch E, Eppinger-Helft M, Braier JL, Pavlovsky S, Guman L, Ver-gara B, Ponzinibbio C, Failace R, Garay GE, Bugnard E, Ojeda FG, Bellis Rde, Sijvarger SR de, Saslavsky J (1978) Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia. Cancer 42:1730
Jacquillat C, Weil M, Auclerc MF, Chastang C, Flandrin G, Izrael V, Schaison G, Degos L, Boiron M, Bernard J (1978) Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 Patients. Cancer Chemother Pharmacol 1:113
Lister TA, Whitehouse JMA, Beard MEJ, Brearley RL, Wrigley PM, Oliver RTD, Freeman JE, Woodruff RK, Malpas JS, Paxton AM, Crowther D (1978) Combination chemotherapy for acute lymphoblastic leukemia in adults. Br Med J 1:199
Henderson ES, Scharlau C, Cooper MR, Haurani FI, Brunner K, Carey RW, Falkson G, Nawabi IV, Levine AS, Bank A, Cuttner J, Cornwell CG, Henry P, Nissen NI, Wiernik PH, Leone L, Wohl H, Rai K, James GW, Weinberg V, Glidewell O, Holland JF (1979) Combi¬nation chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res 3:395
Amadori S, Montuoro A, Meloni G, Spiriti MAA, Pacili, L, Mandelli F (1980) Combination chemotherapy for acute lymphocytic leukemia in adults: results of a retrospective study in 82 patients. Am J Hematol 8:175
Brun B, Vernant JP, Tulliez M, Kuentz M, Deregnaucourt J, Shultze L, Reyes F, Rochant H, Dreyfus B (1980) Acute non myeloid leukemia in adults. Prognostic factors in 92 patients. Scand J Haematol 24:29
Omura GA, Moffitt S, Vogler WR, Salter MM (1980) Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis. Blood 55:199
Willemze R, Drenthe-Schonk AM, van Rossum J, Haanen C (1980) Treatment of acute lymphoblastic leukaemia in adolescents and adults. Comparison of two schedules for CNS leukaemia prophylaxis. Scand J Haematol 24:421–426
Leimert JT, Burns CP, Wiltse CG, Armitage JO, Clarke WR (1980) Prognostic influence of pre treatment characteristics in adult acute lymphoblastic leukemia. Blood 56:510
Baccarani M, Corbelli G, Amadori S, Drenthe-Schonk A, Willemze R, Meloni G, Cardozo PL, Haanen C, Mandelli F, Tura S (1982) Adolescent and adult acute lymphoblastic leukemia: Prognostic features and outcome of therapy. A study of 293 patients. Blood 60:77–684
Blacklock HA, Matthews JRD, Buchanan JG, Ockelford PA, Hill RS (1981) Improved survival from acute lymphoblastic leukemia in adolescents and adults. Cancer 48:1931–1935
Clarkson B, Schauer P, Mertelsmann R, Gee T, Arlin Z, Kempin S, Dowling M, DuFour P, Cirrincione C, Burchenal JH (1981) Results of intensive treatment of acute lymphoblastic leukemia in adults. In: Burchenal JH and Oettgen H (eds) Cancer: Achievements, Challenges and Prospects for the 1980’s, Vol 2, Grune & Stratton, Inc, New York, pp 301–317
Esterhay RJ, Wiernik PH, Grove WR, Markus SD, Wesley MN (1982) Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia. Blood 59:334–345
Amadori S, Meloni G, Baccarani M, Haanen C, Willemze R, Corvelli G, Drenthe-Schonk A, Cardozo PL, Tura S, Mandelli F (1983) Long-term survival in adolescent and adult acute lymphoblastic leukemia. Cancer 52:30–34
Schauer P, Arlin ZA, Mertelsmann R, Cirrincione C, Friedman A, Gee TS, Dowling M, Kempin S, Straus DJ, Koziner B, McKenzie S, Thaler HT, DuFour P, Little C, Dellaquila C, Ellis S, Clarkson B (1983) Treatment of acute lymphoblastic leukemia in adults. Results of the L-10 and L-10 M protocols. J Clin One 1:462–470
Clarkson B, Arlin Z, Gee T, Mertelsmann R, Kempin S, Higgins C, Little C, Cirrincione C (1983) Improved treatment of acute lymphoblastic leukemia (ALL) in adults. Proc Arner Soc Clin One 2:180
Chard RI, Finkelstein JZ, Sonley MJ, Nesbit M, McCreadie S, Weiner J, Sather H, Hammond D (1978) Increased survival in childhood acute non-lymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy. Med Pediatr Oncol 4:263–273
Dahl GV, Simone JV, Hustu HO, Mason C (1978) Preventive central nervous system ir¬radiation in children with acute non-lymphocytic leukemia. Cancer 42:2187–2192
Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62:315–319
Clarkson BD, Dowling MD, Gee TS, Cunningham IB, Burchenal JH (1975) Treatment of acute leukemia in adults. Cancer 36:775–795
Carey RW, Ribas-Mundo M, Ellison RR, Glidwell O, Lee ST, Cuttner J, Levy RN, Silver R, Blom J, Havrani F, Spurr CL, Harley JB, Kyle R, Moon JH, Eagan RT, Holland JH (1975) Comparative study of cytosine arabinoside therapy alone and combined with thio- guanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. Cancer 36:1560–1566
Medical Research Council (1979) Chemotherapy of acute myeloid leukemia in adults. Brit J Cancer 39:69
Gale RP, Foon FA, Cline MJ, Zighelboim J, and the UCLA Acute Leukemia Study Group (1981) Intensive chemotherapy for acute myelogenous leukemia. Ann Intern Med 94:753–757
Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Reisler HD, Nwabi JW, Prager D, Carey RW, Cooper MR, Havrani F, Hutchison JL, Silver RT, Galk-son G, Wiernik P, Hoagland C, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, King F, Henry P, Mclntyre OR, Kaan SK (1981) Treatment of acute myelocytic leukemia: A study by Cancer and Leukemia Group B. Blood 58:1203–1212
Keating MJ, McCredie KB, Bodey GP, Smith TL, Gehan E, Freireich EJ (1982) Improved prospects for long-term survival in adults with acute myelogenous leukemia. JAMA 248:2481–2486
Peterson BA, Bloomfield CC (1981) Long-term disease-free survival in acute nonlympho- eytic leukemia. Blood 57:1144–1147
Lister TA, Whitehouse J MA, Oliver TRD, Bell R, Johnson SA, Wrigley PF, Ford JM, Gul¬len MH, Gregory W, Paxton AM, Malpas JS (1980) Chemotherapy and immunotherapy for acute myelogenous leukemia. Cancer 46:2142–2148
Mertelsmann R, Drapkin RL, Gee TS, Kempin S, Passe S, Thaler HT, Arlin Z, Dowhng MD, DuFour P, McKenzie S, To L, Camacho E, Oettgen HF, Burchenal JH, Clarkson B (1981) Treatment of acute nonlymphocytic leukemia in adults: Response to 2,2-anhydro- l-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol. Cancer 48:2136–2142
Passe S, Mike V, Mertelsmann R, Gee TS, Clarkson B (1982) Acute non-lymphoblastic leukemia: Prognostic factors in adults with long term follow-up. Cancer 50:1462–1471
Arlin Z, Clarkson B (1983) The treatment of acute nonlymphoblastic leukemia in adults. In: Stollerman GH (ed) Advances in Internal Medicine, Vol 28, Year Book Medical Publishers, Inc, New York, pp 303–323
Clarkson BD, Fried J (1971) Changing concepts of treatment in acute leukemia. Med Clin NAmer 55:561–600
Clarkson BD, Haghbin M, Murphy ML, Gee TS, Dowhng MD, Arlin ZA, Kempin S, Posner J, Shapiro W, Galicich J, DuFour P, Passe S, Burchenal JH (1979) Prevention of cen¬tral nervous system leukemia in acute lymphoblastic leukemia with prophylactic chemo¬therapy alone. In: Whitehouse JMA, Kay HEM (eds), CNS Complications of Malignant Disease, MacMillans, London, pp 36–58
Clarkson B, Chou T-C, Strife A, Ferguson R, Sullivan S, Fried J, Kitahara T, Oyama A (1977) Duration of the dormant state in an established cell line of human hematopoietic cells. Cancer Res 37:4506–4522
Arlin ZA, Gee TS, Mertelsmann R, Kempin S, Cirrincione C, Higgins C, Clarkson BD (1983) Treatment of acute lymphoblastic leukemia (ALL) in adults: Comparability of results using extended and brief consolidation therapy. Proc Amer Assoc Cancer Res 24:119
Conjalka M, Jhanwar S, Mertelsmann R, Arlin Z, Koziner B, Chaganti R, Finkbeiner J, Clarkson B (1983) Pretreatment marrow cytogenetic findings in adult acute lymphoblastic leukemia help predict outcome of treatment. Proc Amer Soc Clin One 2:183
Jain K, Arlin Z, Mertelsmann R, Gee T, Kempin S, Koziner B, Middleton A, Jhanwar S, Chaganti R, Clarkson B (1983) Philadelphia chromosome and terminal transferase positive acute leukemia: Similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation. J Clin One 1:669–676
Gee TS, Yu K-P, Clarkson B (1969) Treatment of adult acute leukemia with arabinosyl cytosine and thioguanine. Cancer 23:1019–1032
Arlin ZA, Flomenberg N, Gee TS, Kempin SJ, Dellaquilla C, Mertelsmann R, Straus DJ, Young CW, Clarkson B (1981) Treatment of acute leukemia in relapse with 4’(9-acridinyl- amino)methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. Cancer Clin Trials 4:317–321
Arlin ZA, Gee TS, Mertelsmann R, Kempin SJ, Reich LM, Straus DJ, Higgins C, Clarkson B (1983) Randomized trial of 4’(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside (Ara-C) and thioguanine (TG) vs. daunorubicin with Ara-C and TG in adults with acute non-lymphoblastic leukemia (ANLL). In: Bodey GP and Jacquillat CL (eds) Current Prospectives and Clinical Results with a New AntiCancer Agent, Princeton Communications Medicine for Education, Princeton, New Jersey, pp 77–84
Jacquillat CL, Weil M, Gemon MF (1973) Evaluation of 216 four-year survivors of acute leukemia. Cancer 32:286–293
Whittaker JA, Reizenstein P, Callender ST (1981) Long survival in acute myelogenous leukaemia: An international collaborative study. Brit Med J 282:692–695
Mertelsmann R, Moore MAS, Clarkson B (1982) Leukemic cell phenotype and prognosis: An analysis of 519 adults with acute leukemia. Blood Cells 8:561–583
Keating MJ, Smith TL, Gehan EA, McCredie KB, Bodey GP, Spitzer G, Hersh E, Gut-terman J, Freireich EJ (1980) Factors related to length of complete remission in adult acute leukemia. Cancer 45:2017–2029
Hiddemann W, Büchner T, Andreeff M, Wörmann B, Melamed MR, Clarkson B (1982) Cell kinetics in acute leukemia. A critical re-evaluation based on new data. Cancer 50:250–258
Mertelsmann R, Koziner B, Ralph P, Filippa D, McKenzie S, Arlin ZA, Gee TS, Moore MAS, Clarkson B (1978) Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase positive acute leukemia. Blood 51:1051
Bradstock KF, Hoffbrand AV, Ganeshaguru K, Llewellin P, Patterson K, Wonke B, Prentice AG, Bennett M, Pizzolo G, Bollum FJ, Janossy G (1981) Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukemia: An analysis by immuno¬fluorescence. Brit J Hematol 47:133
Fialkow PJ, Singer JW, Adamson JW, Vaidya K, Dow LW, Ochs J, Moohr JW (1981) Acute non-lymphocytie leukemia: Heterogeneity of stem cell origin. Blood 57:1068
Benedetto P, Mertelsmann RH, Ciobanu N, Gee T, Arlin Z, Kempin S, Clarkson B (1982) Prognostic significance of terminal deoxynucleotidyl transferase (TdT) activity in acute non-lymphoblastic leukemia (ANLL): Evidence for biphenotypic leukemias. Proc Amer Assoc Cancer Res 23:115
Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayr H, McCulloch EA 1982 or 1983. Lineage infidelity in acute leukemia. Blood 61:1138–1145
Moore MAS, Spitzer G, Williams N, Metealf D, Buckley J (1974) Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of re-classification of leukemia according to in vitro growth characteristics. Blood 44:1
Mertelsmann R, Moore MAS, Broxmeyer HE, Cirrineione C, Clarkson BD (1981) The diagnostic and prognostic significance of the CFU-c assay in acute non-lymphoblastic leukemia (ANLL). Cancer Res 41:4844
McCulloch EA, Curtis JE, Messner HA, Senn JS, Germanson TP (1982) The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood 59:601
Rowley JD (1981) Association of specific chromosome abnormalities with type of acute leukemia and with patient age. Cancer Res 41:3407
Arlin Z, Kempin S, Mertelsmann R, Gee T, Higgins C, Clarkson B (1983) Primary therapy of acute promyelocytic leukemia: Results of amsacrine and daunorubicin-based therapy. Blood 63:211–212, 1984
Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Gorg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T, Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:38–47, 1984
Arlin Z, Mertelsmann R, Kempin S, Gee T, Clarkson B (1982) Is further intensification of treatment warranted in acute nonlymphoblastic leukemia? Cancer Treat Rep 67:202–204
Preisler HD (1982) Therapy for patients with acute myelocytic leukemia who enter remis¬sion: bone marrow transplantation or chemotherapy? Cancer Treat Rep 66:1467–1473
Glucksberg H, Cheever MA, Farewell VT, Fefer A, Thomas ED (1983) Intensification therapy for acute nonlymphoblastic leukemia in adults. Cancer 52:198–205
Rees JKH, Sandler RM, Challener J, Hayhoe FGJ (1977) Treatment of acute myeloid leukemia with a triple cytotoxic regime: DAT. Brit J Cancer 36:770–776
Thomas ED, Buckner CD, Clift RA (1979) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301:597–599
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer: Berlin Heidelberg
About this paper
Cite this paper
Clarkson, B. et al. (1984). Current Status of Treatment of Acute Leukemia in Adults: An Overview. In: Büchner, T., Urbanitz, D., van de Loo, J. (eds) Therapie der akuten Leukämien. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69934-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-69934-4_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13682-8
Online ISBN: 978-3-642-69934-4
eBook Packages: Springer Book Archive